Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Belknap

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Annals of Emergency Medicine|February 28, 2002
Adverse drug events in emergency department patientsJohn W Hafner, Steven M Belknap, Marc D Squillante, et al.
Journal of Hospital Medicine|February 16, 2026
Things We Do for No Reason™: Prescribing gabapentinoids for painNiti G Patel, David Goese, Steven M Belknap, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2004
Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individualsShilpa M Patel, Stuart Johnson, Steven M Belknap, et al.
JMIR Medical Informatics|January 21, 2015
Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration's Adverse Event Reporting System NarrativesBalaji Polepalli Ramesh, Steven M Belknap, Zuofeng Li, et al.
Pediatric Dermatology|May 17, 2017
Score of Toxic Epidermal Necrosis Predicts the Outcomes of Pediatric Epidermal NecrolysisJennifer Sorrell, Lisa Anthony, Alfred Rademaker, et al.
Journal of Clinical Medicine Research|May 15, 2013
Characteristics and Causes for Non-Accrued Clinical Research (NACR) at an Academic Medical InstitutionDebra G Tice, Kelly A Carroll, Karishma H Bhatt, et al.
Cancer|March 29, 2006
Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR projectSteven M Belknap, Timothy M Kuzel, Paul R Yarnold, et al.
Drug Safety|January 9, 2015
Risk of anaphylaxis with repeated courses of rasburicase: a Research on Adverse Drug Events and Reports (RADAR) projectKatherine C Allen, Amanda H Champlain, Jonathan A Cotliar, et al.
Peerj|March 15, 2017
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasterideTina Kiguradze, William H Temps, Paul R Yarnold, et al.
Seminars in Thrombosis and Hemostasis|October 9, 2012
Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarinErik Fung, Nikolaos A Patsopoulos, Steven M Belknap, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Annals of Emergency Medicine|February 28, 2002
Adverse drug events in emergency department patientsJohn W Hafner, Steven M Belknap, Marc D Squillante, et al.
Journal of Hospital Medicine|February 16, 2026
Things We Do for No Reason™: Prescribing gabapentinoids for painNiti G Patel, David Goese, Steven M Belknap, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2004
Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individualsShilpa M Patel, Stuart Johnson, Steven M Belknap, et al.
JMIR Medical Informatics|January 21, 2015
Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration's Adverse Event Reporting System NarrativesBalaji Polepalli Ramesh, Steven M Belknap, Zuofeng Li, et al.
Pediatric Dermatology|May 17, 2017
Score of Toxic Epidermal Necrosis Predicts the Outcomes of Pediatric Epidermal NecrolysisJennifer Sorrell, Lisa Anthony, Alfred Rademaker, et al.
Journal of Clinical Medicine Research|May 15, 2013
Characteristics and Causes for Non-Accrued Clinical Research (NACR) at an Academic Medical InstitutionDebra G Tice, Kelly A Carroll, Karishma H Bhatt, et al.
Cancer|March 29, 2006
Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR projectSteven M Belknap, Timothy M Kuzel, Paul R Yarnold, et al.
Drug Safety|January 9, 2015
Risk of anaphylaxis with repeated courses of rasburicase: a Research on Adverse Drug Events and Reports (RADAR) projectKatherine C Allen, Amanda H Champlain, Jonathan A Cotliar, et al.
Peerj|March 15, 2017
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasterideTina Kiguradze, William H Temps, Paul R Yarnold, et al.
Seminars in Thrombosis and Hemostasis|October 9, 2012
Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarinErik Fung, Nikolaos A Patsopoulos, Steven M Belknap, et al.
Pageof 3